On Monday, Glaukos Corporation (NYSE: GKOS) was 3.15% up from the session before settling in for the closing price of $90.07. A 52-week range for GKOS has been $77.91 – $163.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.99%. When this article was written, the company’s average yearly earnings per share was at 47.36%. With a float of $54.47 million, this company’s outstanding shares have now reached $56.44 million.
Let’s determine the extent of company efficiency that accounts for 995 employees. In terms of profitability, gross margin is 75.48%, operating margin of -28.2%, and the pretax margin is -37.97%.
Glaukos Corporation (GKOS) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Glaukos Corporation stocks. The insider ownership of Glaukos Corporation is 3.71%, while institutional ownership is 101.28%. The most recent insider transaction that took place on Mar 25 ’25, was worth 162,399. In this transaction SVP & CHIEF FINANCIAL OFFICER of this company sold 1,520 shares at a rate of $106.84, taking the stock ownership to the 53,431 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Officer proposed sale 1,520 for $106.84, making the entire transaction worth $162,402.
Glaukos Corporation (GKOS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 47.36% per share during the next fiscal year.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
You can see what Glaukos Corporation (GKOS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Looking closely at Glaukos Corporation (NYSE: GKOS), its last 5-days average volume was 1.02 million, which is a jump from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 57.25%. Additionally, its Average True Range was 6.82.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 17.48%, which indicates a significant decrease from 51.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.49% in the past 14 days, which was higher than the 64.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $115.69, while its 200-day Moving Average is $129.61. However, in the short run, Glaukos Corporation’s stock first resistance to watch stands at $94.04. Second resistance stands at $95.18. The third major resistance level sits at $97.12. If the price goes on to break the first support level at $90.96, it is likely to go to the next support level at $89.02. Now, if the price goes above the second support level, the third support stands at $87.88.
Glaukos Corporation (NYSE: GKOS) Key Stats
There are 56,567K outstanding shares of the company, which has a market capitalization of 5.26 billion. As of now, sales total 383,480 K while income totals -146,370 K. Its latest quarter income was 105,500 K while its last quarter net income were -33,580 K.
